By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mersana Therapeutics, Inc. 

840 Memorial Drive
2nd Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a



Company News
Mersana Therapeutics, Inc. Strengthens Antibody-Drug Conjugate Intellectual Property Position With Issuance Of Three Additional U.S. Patents 9/9/2014 10:57:39 AM
Cambridge-Based Mersana Therapeutics, Inc. Strikes New Oncology Pact Worth $792 Million With Merck KGaA (MKGAF.PK) 6/24/2014 6:59:25 AM
Mersana Therapeutics, Inc. Enters Collaboration With Takeda Pharmaceutical Co. Ltd. (TKPYY) To Develop Next-Generation Antibody-Drug Conjugates 4/7/2014 10:08:46 AM
Mersana Therapeutics, Inc. Awarded Patent With Broad Coverage For Fleximer-ADC Platform Technology 4/2/2014 9:55:20 AM
Mersana Therapeutics, Inc. Earns Second Milestone Payment In Fleximer-ADC Collaboration With Endo Pharmaceuticals (ENDP) 1/9/2014 10:12:24 AM
Mersana Therapeutics, Inc. Appoints Donald A. Bergstrom, M.D., Ph.D., And Eva M. Jack To Executive Leadership Positions 1/8/2014 8:42:15 AM
Mersana Therapeutics, Inc. Forms Scientific Advisory Board to Support Development of Next-Generation Antibody-Drug Conjugates 10/21/2013 6:45:48 AM
Mersana Therapeutics, Inc. Earns Milestone Payment in Fleximer-ADC Collaboration With Endo Pharmaceuticals (ENDP) 10/15/2013 9:54:54 AM
Adimab LLC. and Mersana Therapeutics, Inc. Announce Antibody-Drug Conjugate Alliance 8/1/2012 10:18:07 AM
Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates 7/31/2012 8:12:12 AM